Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최남경 | * |
dc.date.accessioned | 2024-02-06T16:31:21Z | - |
dc.date.available | 2024-02-06T16:31:21Z | - |
dc.date.issued | 2023 | * |
dc.identifier.issn | 1198-743X | * |
dc.identifier.other | OAK-34499 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/267068 | - |
dc.description.abstract | Objectives: Despite some evidence of an increased risk of neurologic symptoms following viral vector COVID-19 vaccine administration, it is unclear whether SARS-CoV-2 infection is associated with Bell's palsy (BP), especially over a long enough follow-up period. Methods: The study population of this nationwide population-based study was derived from the South Korean population, including 11 593 365 and 36 565 099 participants with and without COVID-19, respectively. The Fine and Gray's regression model was utilized to calculate the adjusted subdistribution hazard ratio (aSHR), considering death as a competing risk, to assess the association between SARS-CoV-2 infection and the risk of BP. All participants were followed up from 1 December 2021, until the incident BP, SARS-CoV-2 infection, death, or 31 March 2022. Subgroup analyses were conducted based on participants' vaccination status (completion of the primary series vs. unvaccinated). Results: COVID-19 was associated with an increased risk of BP in all participants (aSHR, 1.24; CI, 1.19–1.29). However, the size of the COVID-19–related BP risk was significantly lower among those who completed the primary series of the COVID-19 vaccine (aSHR, 1.20; 95% CI, 1.15–1.25) compared to those who were unvaccinated (aSHR, 1.84; 95% CI, 1.59–2.12; p for interaction: <0.001). The severity of COVID-19 exhibited a gradual escalation in BP risk for both vaccinated and unvaccinated individuals. Discussion: While both unvaccinated individuals and those who completed the primary series of the COVID-19 vaccine may be at an increased risk of developing BP due to COVID-19, the risk appears to be lower among those who completed the vaccination. © 2023 European Society of Clinical Microbiology and Infectious Diseases | * |
dc.language | English | * |
dc.publisher | Elsevier B.V. | * |
dc.subject | Bell's palsy | * |
dc.subject | COVID-19 | * |
dc.subject | COVID-19 vaccine | * |
dc.subject | Mass screening | * |
dc.subject | Public health | * |
dc.subject | SARS-CoV-2 | * |
dc.title | Risk of Bell's palsy following SARS-CoV-2 infection: a nationwide cohort study | * |
dc.type | Article | * |
dc.relation.issue | 12 | * |
dc.relation.volume | 29 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 1581 | * |
dc.relation.lastpage | 1586 | * |
dc.relation.journaltitle | Clinical Microbiology and Infection | * |
dc.identifier.doi | 10.1016/j.cmi.2023.08.014 | * |
dc.identifier.wosid | WOS:001127955400001 | * |
dc.identifier.scopusid | 2-s2.0-85169512665 | * |
dc.author.google | Kim | * |
dc.author.google | Hye Jun | * |
dc.author.google | Jeong | * |
dc.author.google | Seogsong | * |
dc.author.google | Song | * |
dc.author.google | Jihun | * |
dc.author.google | Park | * |
dc.author.google | Sun Jae | * |
dc.author.google | Oh | * |
dc.author.google | Yun Hwan | * |
dc.author.google | Jung | * |
dc.author.google | Jaehun | * |
dc.author.google | Choi | * |
dc.author.google | Nam-Kyong | * |
dc.author.google | Sang Min | * |
dc.contributor.scopusid | 최남경(35486895900) | * |
dc.date.modifydate | 20240304125908 | * |